CompoAtlas

Wonder Men Prostate Health

Natural health product licensed in Canada

Licence holder
Wonder Naturals Inc.
NPN or DIN-HM
80058425
Status
Active licence
Licence date
24 February 2015
Revision date
27 March 2015
Form
Capsule, dur
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Euryale ferox

Source : Euryale ferox seed

150 milligrammeNot calculated
Eucommia ulmoides

Source : Écorce (tige)

Extract : Matériel brut sec

Extraction ratio : 20:1

Dry plant equivalent : 3,600 milligramme

180 milligrammeNot calculated
Lycium barbarum

Source : Lycium barbarum - Fruit

180 milligrammeNot calculated
Serenoa repens

Source : Serenoa repens - fruit

Extract : Matériel brut sec

Extraction ratio : 1.1:1

Dry plant equivalent : 198 milligramme

Potency : 75 % Free fatty acids, esters, and sterols

180 milligrammeNot calculated
psi,psi-carotène

Source : Solanum lycopersicum - Chair (fruit)

8 milligrammeNot calculated

Non-medicinal ingredients

Stéarate de magnésium, Gélatine, cellulose

PopulationAgeQuantity per servingFrequency
Adultes de sexe masculinNot specified2 Capsule1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

American ginseng is traditionally used in Herbal Medicine to help maintain a healthy immune system. Provides antioxidants for the maintenance of good health. Helps to support prostate health. Used in Herbal Medicine to help relieve the urologic symptoms (e.g. weak urine flow, incomplete voiding, frequent daytime and night time urination) associated with mild to moderate benign prostatic hyperplasia.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80058425

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2015. Photograph the packaging to check whether it has changed. Photograph the packaging

List recorded in 2015. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line